BB1 Acquisition Corp.

Recent News

  • BB1 Acquisition Corp. and Cerrado Gold Inc. Announce Closing of the Second and Final Tranche of Special Warrant Offering for Gross Proceeds of US$1,724,000

    Toronto, Ontario--(Newsfile Corp. - September 14, 2020) - BB1 Acquisition Corp. (TSXV: BBA.P) (the "Company" or "BB1") and Cerrado Gold Inc. ("Cerrado") are pleased to announce that Cerrado has completed the second and final tranche of a brokered private placement of special warrants ("Special Warrants") for aggregate gross proceeds of approximately US$1,724,000. Total funds raised under the first and second tranche of the Cerrado placement (the "Offering") were US$7,076,600. Haywood Securities Inc. (the "Agent") acted as sole agent in...

    2020-09-14 7:00 AM ET
  • BB1 Acquisition Corp. and Cerrado Gold Inc. Announce Closing of First Tranche of Special Warrant Offering for Gross Proceeds of Us$5,352,000

    Toronto, Ontario--(Newsfile Corp. - August 27, 2020) - BB1 Acquisition Corp. (TSXV: BBA.P) (the "Company" or "BB1") and Cerrado Gold Inc. ("Cerrado") are pleased to announce that Cerrado has completed a first tranche of a brokered private placement (the "Offering") of special warrants ("Special Warrants") for aggregate gross proceeds of approximately US$5,352,000. Haywood Securities Inc. (the "Agent") acted as sole agent in the Offering. The Offering has been completed in connection with the proposed business combination (the "Transaction")...

    2020-08-27 3:48 PM ET
  • BB1 Acquisition Corp. Announces Proposed Qualifying Transaction with Cerrado Gold Inc.

    Toronto, Ontario--(Newsfile Corp. - August 4, 2020) -  BB1 Acquisition Corp. (TSXV: BBA.P) ("BB1" or the "Company"), a capital pool company, and Cerrado Gold Inc. ("Cerrado") are pleased to announce that they have entered into a binding Letter of Intent, dated August 4, 2020 (the "LOI"), which sets forth the general terms and conditions of a proposed transaction (the "Transaction") pursuant to which BB1 will acquire all of the issued and outstanding shares of Cerrado. The Transaction will constitute...

    2020-08-04 5:49 PM ET
  • BB1 Acquisition Corp. Announces Termination of Proposed Qualifying Transaction with PlantExt Ltd.

    Toronto, Ontario--(Newsfile Corp. - January 24, 2020) - BB1 Acquisition Corp. (TSXV: BBA.P) ("BB1" or the "Corporation"), a capital pool company, announces the termination of its proposed three-cornered amalgamation (the "PlantExt Transaction") with PlantExt Ltd. ("PlantExt"). The PlantExt Transaction, first announced by the Corporation on January 24, 2019, was intended to constitute BB1's "Qualifying Transaction" as such term is defined in Policy 2.4 of the TSX Venture Exchange ("TSXV" or the "Exchange").The terms of the share exchange agreement between the...

    2020-01-24 10:27 AM ET
  • BB1 Acquisition Corp. Enters Into Definitive Agreement with PlantEXT Ltd. to Complete Business Combination

    Toronto, Ontario--(Newsfile Corp. - August 19, 2019) - PlantEXT Ltd. ("PlantEXT") and BB1 Acquisition Corp. (TSXV: BBA.P) ("BB1" or the "Company"), a capital pool company as defined under Policy 2.4 - Capital Pool Companies (the "Policy") of the TSX Venture Exchange (the "Exchange"), are pleased to announce that they have entered into a definitive share exchange agreement (the "Definitive Agreement") pursuant to which PlantEXT and BB1 will effect a transaction that will result in a reverse takeover of BB1...

    2019-08-19 9:00 AM ET
  • PlantEXT Engages Beacon Securities Limited for $7-Million USD Brokered Private Placement

    Toronto, Ontario--(Newsfile Corp. - July 10, 2019) - PlantEXT Ltd. ("PlantEXT" or the "Company") and BB1 Acquisition Corp. (TSXV: BBA.P) ("BB1") are pleased to announce that PlantEXT, a leader in the development and commercialization of pharmaceutical cannabis formulations for the treatment of inflammation related medical conditions, has entered into an engagement letter with Beacon Securities Limited ("Beacon") to conduct a brokered private placement of ordinary shares (each an "Offered Security") at a price of US$1.25 (the "Issue Price") per Offered...

    2019-07-10 12:01 AM ET
  • PlantEXT and Family Secret Execute Joint Venture Agreement to Develop, Produce and Market Topical Medical Cannabis Products

    Toronto, Ontario--(Newsfile Corp. - April 29, 2019) - PlantEXT Ltd. ("PlantEXT") and BB1 Acquisition Corp. (TSXV: BBA.P) ("BB1") are pleased to announce that PlantEXT, a leader in the development and commercialization of medical cannabis formulations for the treatment of inflammation related medical conditions, has entered into a joint venture agreement (the "JV") with Family Secret Ltd. ("Family Secret") an established, Israeli formulation developer and manufacturer of all-natural medical skin care products.Doug Sommerville, CEO of PlantEXT stated, "PlantEXT and Family Secret...

    2019-04-29 12:01 AM ET
  • PlantEXT and Israel's Agricultural Research Organization Report Progress on Research and Development of Medical Cannabis Formulations for Inflammatory Bowel Disease

    Toronto, Ontario--(Newsfile Corp. - April 11, 2019) - PlantEXT Ltd. ("PlantEXT") and BB1 Acquisition Corp. (TSXV: BBA.P) ("BB1") are pleased to announce that following more than three years of dedicated research in the laboratory of Prof. Hinanit Koltai, Agricultural Research Organization ("ARO"), PlantEXT and the State of Israel's ARO, have successfully refined earlier discoveries to develop active, anti-inflammatory formulations of cannabinoids and terpenes derived from cannabis. In vitro testing on human cell lines and ex vivo testing on inflamed colon...

    2019-04-11 12:01 AM ET